Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Motzny

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular & Cellular Proteomics : MCP|August 27, 2005
GYF domain proteomics reveals interaction sites in known and novel target proteinsMichael Kofler, Kathrin Motzny, Christian Freund
The Journal of Biological Chemistry|July 8, 2005
Novel interaction partners of the CD2BP2-GYF domainMichael Kofler, Kathrin Motzny, Michael Beyermann, et al.
Nature Communications|August 21, 2025
Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction networkAndromachi Papagiannoula, Ida Marie Vedel, Kathrin Motzny, et al.
Nature Communications|July 13, 2024
An extended interaction site determines binding between AP180 and AP2 in clathrin mediated endocytosisSamuel Naudi-Fabra, Carlos A Elena-Real, Ida Marie Vedel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2025
Ena/VASP-EVH1 inhibition prevents chemotaxis and metastasis by blocking the EVH1-WAVE2 interactionMatthias Müller, Matthias Barone, Maarten van Dinther, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2020
Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cellsMatthias Barone, Matthias Müller, Slim Chiha, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular & Cellular Proteomics : MCP|August 27, 2005
GYF domain proteomics reveals interaction sites in known and novel target proteinsMichael Kofler, Kathrin Motzny, Christian Freund
The Journal of Biological Chemistry|July 8, 2005
Novel interaction partners of the CD2BP2-GYF domainMichael Kofler, Kathrin Motzny, Michael Beyermann, et al.
Nature Communications|August 21, 2025
Promiscuous and multivalent interactions between Eps15 and partner protein Dab2 generate a complex interaction networkAndromachi Papagiannoula, Ida Marie Vedel, Kathrin Motzny, et al.
Nature Communications|July 13, 2024
An extended interaction site determines binding between AP180 and AP2 in clathrin mediated endocytosisSamuel Naudi-Fabra, Carlos A Elena-Real, Ida Marie Vedel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2025
Ena/VASP-EVH1 inhibition prevents chemotaxis and metastasis by blocking the EVH1-WAVE2 interactionMatthias Müller, Matthias Barone, Maarten van Dinther, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2020
Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cellsMatthias Barone, Matthias Müller, Slim Chiha, et al.
Pageof 1